Any claim that spending on the PBS is stagnant belies $3.3 billion in topline growth, representing the program's single biggest year-on-year financial expansion in its 75-year history, $7 billion in new listings over 18 months, Budget rules and the impact of the industry's agreements with the federal government.
Far from 'stagnating', the PBS has delivered record growth as it rapidly approaches $20 billion
May 10, 2023 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Cartherics and Catalent deepen partnership to accelerate next generation cell therapies
April 10, 2026 - - Australian Biotech -
Lower official co-payment but patients paying for more unsubsidised medicines
April 10, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 10 April
April 10, 2026 - - Podcast -
Is there any example of another review or inquiry taking this long?
April 10, 2026 - - Latest News -
Rewriting the rules of PBS negotiations to deliver a patient-first reset
April 10, 2026 - - Latest News -
A decade of readiness as AVITA medical expands burn response capability
April 9, 2026 - - Australian Biotech -
Moderna names Carolyn Tucek-Szabo to lead Australia and New Zealand operations
April 9, 2026 - - Latest News
